High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma

Mark Raffeld; Zied Abdullaev; Svetlana D. Pack; Liqiang Xi; Sushma Nagaraj; Nicole Briceno; Elizabeth Vera; Stefania Pittaluga; Osorio Lopes Abath Neto; Martha Quezado; Kenneth Aldape; Terri S. Armstrong; Mark R. Gilbert

doi:10.1186/S40478-020-00973-Y

High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma

Mark Raffeld, Zied Abdullaev, Svetlana D. Pack, Liqiang Xi, Sushma Nagaraj, Nicole Briceno, Elizabeth Vera, Stefania Pittaluga, Osorio Lopes Abath Neto, Martha Quezado, Kenneth Aldape, Terri S. Armstrong, Mark R. Gilbert

National Institutes of Health

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Acta neuropathologica communications
Volume	8
Issue number	1
DOIs	https://doi.org/10.1186/S40478-020-00973-Y
State	Published - Jul 8 2020
Externally published	Yes

Disciplines

Neurology
Pathology
Medicine and Health Sciences

Access to Document

10.1186/S40478-020-00973-YLicense: Unspecified

Cite this

Raffeld, M., Abdullaev, Z., Pack, S. D., Xi, L., Nagaraj, S., Briceno, N., Vera, E., Pittaluga, S., Neto, O. L. A., Quezado, M., Aldape, K., Armstrong, T. S., & Gilbert, M. R. (2020). High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma. Acta neuropathologica communications, 8(1). https://doi.org/10.1186/S40478-020-00973-Y

Raffeld, M, Abdullaev, Z, Pack, SD, Xi, L, Nagaraj, S, Briceno, N, Vera, E, Pittaluga, S, Neto, OLA, Quezado, M, Aldape, K, Armstrong, TS & Gilbert, MR 2020, 'High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma', Acta neuropathologica communications, vol. 8, no. 1. https://doi.org/10.1186/S40478-020-00973-Y

@article{48908fbe1dc44f02abef596aedcf23f5,

title = "High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma",

author = "Mark Raffeld and Zied Abdullaev and Pack, {Svetlana D.} and Liqiang Xi and Sushma Nagaraj and Nicole Briceno and Elizabeth Vera and Stefania Pittaluga and Neto, {Osorio Lopes Abath} and Martha Quezado and Kenneth Aldape and Armstrong, {Terri S.} and Gilbert, {Mark R.}",

year = "2020",

month = jul,

day = "8",

doi = "10.1186/S40478-020-00973-Y",

language = "American English",

volume = "8",

journal = "Acta neuropathologica communications",

number = "1",

}

TY - JOUR

T1 - High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma

AU - Raffeld, Mark

AU - Abdullaev, Zied

AU - Pack, Svetlana D.

AU - Xi, Liqiang

AU - Nagaraj, Sushma

AU - Briceno, Nicole

AU - Vera, Elizabeth

AU - Pittaluga, Stefania

AU - Neto, Osorio Lopes Abath

AU - Quezado, Martha

AU - Aldape, Kenneth

AU - Armstrong, Terri S.

AU - Gilbert, Mark R.

PY - 2020/7/8

Y1 - 2020/7/8

UR - https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-020-00973-y

U2 - 10.1186/S40478-020-00973-Y

DO - 10.1186/S40478-020-00973-Y

M3 - Article

VL - 8

JO - Acta neuropathologica communications

JF - Acta neuropathologica communications

IS - 1

ER -

High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma

Disciplines

Access to Document

Other files and links

Cite this